Related Experiment Video
Updated: Jun 2, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Equitable Global Representation in Cardiovascular Guidelines and Clinical Trials: Lacunae Remain
Vivek Bhat1, Thomas J Fretz2,3, Ankur Kalra3,4
1Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.
No abstract available in PubMed .
More Related Videos
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Clinical Trials: Overview
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...